Visium Asset Management Ups Stake in Skyrocketing Intercept Pharmaceuticals Inc (ICPT)

Jacob Gottlieb‘s Visium Asset Management has increased its stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), according to an amended filing with the SEC. Gottlieb’s fund now holds 1.04 million shares of Intercept, compared to the 767,015 they previously held. Visium now holds 5.2% of Intercept’s shares.

Intercept Pharmaceuticals is focused on the development and commercialization of therapeutics to treat chronic liver diseases utilizing its bile acid chemistry. Gottlieb upped the company’s stake in Intercept amid news that the company’s liver-disease drug performed well in a clinical trial leading to a near quadrupling of the company’s stock price.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

The company recently announced that their decision to halt an experimental drug trial early as patients showed “significant improvement” compared to a placebo.

According to Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Chief Executive and co-founder Mark Pruzanski, “We didn’t expect this. The bar for stopping the study for efficacy was so high from a statistical significance standpoint that on an interim analysis like this, it seemed out of sight. We couldn’t be happier with the result.”

The trial was for a beticholic acid, or OCA, drug. Reportedly, OCA imitates the liver’s naturally occurring protective bile. The drug is designed for patients afflicted with nonalcoholic steatohepatitis. The disease, which has no symptoms initially, can lead to cirrhosis and liver failure. Further, there are no cures for the disease currently.

The drug, called obeticholic acid, or OCA, mimics a naturally occurring human bile acid that Intercept believes has liver-protective properties. The National Institute of Diabetes and Digestive and Kidney Diseases sponsored a clinical trial of the drug in patients with a condition known as nonalcoholic steatohepatitis, which involves fat accumulation in the liver that can cause inflammation and lead to the more serious conditions of cirrhosis and liver failure. The disease progresses over many years and often has no symptoms in the early stages. Further, 2-5% of Americans suffer from nonalcoholic steatohepatitis.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)’s stock is up an incredible 717% over the past year and more than 350% over the past month. The 45-person company is yet to put a product on the market, even though it was founded in 2002. According to FactSet Research Systems Inc, the company recently experienced the most significant single-day jim among companies of at least $1 billion in market value since 2012.

In addition to Visium Asset Management, Steve Cohen is also bullish on Intercept Pharmaceuticals Inc (NASDAQ:ICPT): His SAC Capital Advisors opened a 5.3% position in the company in November. Missing out on the rally, in part, was Samuel Isaly’s Orbimed Advisors. In late October, Orbimed unloaded a part of its shares of the Intercept. Even though, following the sale, Orbimed still owns around 1.7 million shares of the company, its stake is significantly lower than 2.15 million shares held at the end of September according to latest 13F.

Disclosure: None

Recommended Reading:

Ariel Investments Boosts its Exposure to Rosetta Stone Inc (RST), Spartan Motors Inc (SPAR) and Sigma Designs Inc (SIGM)

First Eagle Investment Management Slices Stake in UniFirst Corp (UNF)

Ardsley Partners Increases Holding in World Energy Solutions, Inc. (XWES)

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!